TREK Antibodies

Santa Cruz Biotechnology features a diverse variety of TREK Antibodies for advanced research in ion channel biology. TREK Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TREK proteins, part of the two-pore domain potassium channel family, play a crucial role in regulating cellular excitability and maintaining the resting membrane potential. TREK channels are actively involved in neuronal signaling, cardiac function, and response to mechanical stress. Research focusing on TREK proteins continues to reveal significant insights into health and disease, particularly in conditions such as pain, ischemia, and neurodegenerative disorders. Scientists worldwide utilize TREK monoclonal antibodies to advance their understanding of ion channel dynamics and cellular signaling pathways. Ongoing studies of TREK channels have highlighted their importance in maintaining cellular homeostasis and their potential as therapeutic targets. TREK monoclonal antibodies from Santa Cruz Biotechnology enable researchers to make meaningful contributions to the scientific understanding of ion channel biology and its impact on human health.